Life Science Industry Updates


  • All
  • Manufacturing
  • Marketing
  • Biotech
  • All

    BMS’ Opdivo and Yervoy Combination Treatment Snags Two Approvals in Lung Cancer this Month

    BMS’ Opdivo and Yervoy Combination Treatment Snags Two Approvals in Lung Cancer this Month

    Share with a colleague. Biospace

    Q32 Bio Launches with $46 Million and IL-7 Inhibitor Licensed from BMS

    You’ll want to read this between meetings. Biospace

    AbCellera Raises $105 Million Series B to Expand Therapeutic Antibody Manufacturing

    Expert thoughts. Biospace

    Venture capital found its footing in biotech. Then came the virus.

    Sit down for this one. BioPharma Dive

    Trump administration touts plan to limit insulin costs for seniors

    So relevant. BioPharma Dive

    WuXi upgrades CAR-T offerings with new manufacturing platform

    Who do you know who’d find this relevant? Fierce Pharma

    Takeda's Alunbrig scores nod for earlier lung cancer use, but a Roche showdown awaits

    Straight from the SOURCE. Fierce Pharma

    NGOs slam 'extremely dubious priorities' of EU R&D program

    Explore recent news. Fierce Biotech

    Sponsored Ad

    Featured

    Genentech Launches COVID-19 Study Focused on Underserved Minority Populations

    Genentech Launches COVID-19 Study Focused on Underserved Minority Populations

    Stay connected to what’s happening in Life Sciences. Biospace

    Biopharma Update on the Novel Coronavirus: May 27

    Have you read this yet? Biospace

    Gilead Doubles Down on Immuno-Oncology with 10-Year Pact with Arcus Biosciences

    Share with your team. Biospace

    Sponsored Ad

    U.K. grants early access to Gilead's remdesivir for COVID-19 patients

    Passing this around on e-mail today. BioPharma Dive

    Gilead puts $375M into Arcus in latest push to broaden cancer business

    This is what’s on our minds. BioPharma Dive

    How Civica helped under-the-radar Phlow nab a $354M COVID-19 manufacturing deal

    Worth the read. Fierce Pharma

    Bristol Myers Squibb's Opdivo, Yervoy score another lung cancer OK, this time alongside chemo

    What do you think? Fierce Pharma

    Gilead pens $2B Arcus pact for immuno-oncology targets of the past and future

    You heard it from SOURCE EXPLORER. Fierce Biotech

    SOURCE EXPLORER Updates

    Laugh for Life Sciences: 10 #Coronalife Work-From-Home Fails

    Laugh for Life Sciences: 10 #Coronalife Work-From-Home Fails

    Sponsored Ad

    Calling All Life Science Professionals: Are You an Introvert or Extrovert?

    Calling All Life Science Professionals: Are You an Introvert or Extrovert?

    Proposed Incentives for Life Sciences Industry

    Proposed Incentives for Life Sciences Industry

    Pharma Companies Killing It with Social Media

    Pharma Companies Killing It with Social Media

    Gene Therapy: What It Means for the Future of Healthcare

    Gene Therapy: What It Means for the Future of Healthcare

    View all Updates